“We are pleased that more than 500,000 women’s mammograms have been analyzed using the Volpara breast density software as it marks a significant milestone in the growing international acceptance of our technology,” said Ralph Highnam, PhD, CEO.
WELLINGTON, NEW ZEALAND (PRWEB) November 21, 2012
Designed to improve early detection among women with dense breasts, Matakina International today announced that more than 500,000 women have now been measured using its Volpara Breast Density Assessment software. Offering objective breast density measurements for mammograms acquired from any commercially available digital mammography system, Volpara generates objective, automatic measurement of volumetric breast density values along with a BIRADS Breast Density Classification.
This milestone was achieved at one of the recent enterprise-wide installations of Volpara breast density measurement software, which includes Reading Hospital and Medical Center in West Reading, Penn., El Camino Hospital, in Mountain View, Calif., or the University of Virginia Health System in Charlottesville, Va.
These enterprise-wide installations provide the institutions with the ability to offer objective breast density assessment for all mammograms acquired on Hologic, Siemens, GE or other digital mammography equipment at all of their facilities from a single source which resides on a server housed in a central location. This provides institutions and their patients the latest technology available while meeting the needs of any facility with multiple locations. Adoption of the Microsoft Windows-based Volpara Enterprise solution also allows for greater flexibility for IT infrastructure and a reduction in service costs.
Reading Hospital and Medical Center performs more than 35,000 mammograms annually and the Enterprise installation provides the ability to offer objective breast density measurements for all mammograms performed on seven Hologic Mammography Systems at the Hospital and three outpatient imaging sites. University of Virginia has five GE and Hologic mammography systems spread over three sites; whilst El Camino has three Siemens mammography systems at two sites.
“It is critical for physicians and patients to have as many resources available as possible to detect breast cancer, especially among women for whom the traditional mammogram may not be enough,” said Imtiaz Qureshi, MD, medical director and chief of radiology at El Camino Hospital in Mountain View. “Volpara, when used in concert with advanced imaging technology, can increase the chances for an accurate diagnosis leading to early treatment and a greater possibility for long-term survival.”
Cleared by the FDA, HealthCanada, the TGA and CE-marked, Volpara is in use at sites across the globe helping radiologists assess breast density more objectively and helping them better consider who might benefit from additional screening. Volpara is a reliable tool which automatically generates objective, automatic measurement of volumetric breast density values under the Volpara Density Grade (VDG®), a refined grading system which correlates with the American College of Radiology BIRADS Density Grading Classifications. Volpara is FDA cleared for all digital mammography units, and integration with other digital mammography systems, CAD systems and mammography reporting system are also underway.
“We are particularly pleased that more than 500,000 women’s mammograms have been analyzed using the Volpara breast density software as it marks a significant milestone in the growing international acceptance of our technology,” said Ralph Highnam, PhD, CEO of Matakina International. “It is particularly fitting that we reached this milestone at one of these institutes, which all have a strong reputation for incorporating state-of-the art technology to provide the highest quality care for all of their patients. We are very proud to work closely with them to implement Enterprise-wide solutions connecting many different kinds of mammography systems at different sites to ensure that every patient that gets a mammogram has the benefit of an objective, accurate breast density measurement.”
Founded to enable radiologists to give women the most accurate information possible regarding their breast health, Matakina International, Limited is the wholly owned sales and marketing arm of Matakina Technology Limited of New Zealand. Volpara’s founders and Board of Directors includes John Hood, PhD, former Vice Chancellor of the University of Oxford, UK, Ralph Highnam, PhD, former CEO of Mirada Solutions, one of the University of Oxford’s most successful spin-outs of recent times and co-author of the seminal book Mammographic Image Analysis; and Professor Sir Michael Brady, a serial entrepreneur who recently retired from the University of Oxford where he was Professor of Information Technology for 25 years.
# # #
Chris K. Joseph